Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation

Hepatitis C virus (HCV) is a pathogen characterized not only by its persistent infection leading to the development of cirrhosis and hepatocellular carcinoma (HCC), but also by metabolic disorders such as lipid and iron dysregulation. Elevated iron load is commonly observed in the livers of patients with chronic hepatitis C, and hepatic iron overload is a highly profibrogenic and carcinogenic factor that increases the risk of HCC. However, the underlying mechanisms of elevated iron accumulation in HCV-infected livers remain to be fully elucidated. Here, we observed iron accumulation in cells and liver tissues under HCV infection and in mice expressing viral proteins from recombinant adenoviruses. We established two molecular mechanisms that contribute to increased iron load in cells caused by HCV infection. One is the transcriptional induction of hepcidin, the key hormone for modulating iron homeostasis. The transcription factor cAMP-responsive element-binding protein hepatocyte specific (CREBH), which was activated by HCV infection, not only directly recognizes the hepcidin promoter but also induces bone morphogenetic protein 6 (BMP6) expression, resulting in an activated BMP-SMAD pathway that enhances hepcidin promoter activity. The other is post-translational regulation of the iron-exporting membrane protein ferroportin 1 (FPN1), which is cleaved between residues Cys284 and Ala285 in the intracytoplasmic loop region of the central portion mediated by HCV NS3-4A serine protease. We propose that host transcriptional activation triggered by endoplasmic reticulum stress and FPN1 cleavage by viral protease work in concert to impair iron efflux, leading to iron accumulation in HCV-infected cells.

[1]  N. Luhmann,et al.  New WHO guidance for country validation of viral hepatitis B and C elimination. , 2021, The lancet. Gastroenterology & hepatology.

[2]  Irum Rehman,et al.  Correlation Between Serum Ferritin and Hepcidin Levels in Chronic Hepatitis C Patients , 2021, Cureus.

[3]  K. Shinmura,et al.  Diagnosis of Ion-Exchange Resin Depositions in Paraffin Sections Using Corrective Light and Electron Microscopy-NanoSuit Method , 2021, Diagnostics.

[4]  F. Penin,et al.  OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease , 2020, PloS one.

[5]  R. Dror,et al.  Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms , 2020, Nature.

[6]  B. Lindenbach,et al.  Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase , 2020, The Journal of Biological Chemistry.

[7]  H. Sugimura,et al.  Utility of Scanning Electron Microscopy Elemental Analysis Using the ‘NanoSuit’ Correlative Light and Electron Microscopy Method in the Diagnosis of Lanthanum Phosphate Deposition in the Esophagogastroduodenal Mucosa , 2019, Diagnostics.

[8]  Liyun Shi,et al.  Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma. , 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[9]  Y. Takaku,et al.  The NanoSuit method: a novel histological approach for examining paraffin sections in a nondestructive manner by correlative light and electron microscopy , 2019, Laboratory Investigation.

[10]  C. Webber,et al.  Antiviral activity of bone morphogenetic proteins and activins , 2018, Nature Microbiology.

[11]  R. Flisiak,et al.  Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C , 2017, Clinical and experimental hepatology.

[12]  Masahiro Yamamoto,et al.  Critical role of CREBH‐mediated induction of transforming growth factor β2 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells , 2017, Hepatology.

[13]  O. Nureki,et al.  Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin , 2015, Nature Communications.

[14]  Xiaozhou He,et al.  Decreased expression of ferroportin in prostate cancer. , 2015, Oncology letters.

[15]  F. Zhan,et al.  Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation. , 2015, Cancer research.

[16]  K. Bielawski,et al.  Association of Hepcidin mRNA Expression With Hepatocyte Iron Accumulation and Effects of Antiviral Therapy in Chronic Hepatitis C Infection , 2014, Hepatitis monthly.

[17]  Zhigang Zhang,et al.  Duodenal Ferroportin Is Up-Regulated in Patients with Chronic Hepatitis C , 2014, PloS one.

[18]  W. Hörl,et al.  Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Céline Hernandez,et al.  Quantitative proteomics identifies the membrane‐associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3‐4A protease , 2014, Hepatology.

[20]  C. Fillebeen,et al.  Hepatitis C Virus Infection Causes Iron Deficiency in Huh7.5.1 Cells , 2013, PloS one.

[21]  A. Ido,et al.  Hepatitis C Virus NS3/4A Protease Inhibits Complement Activation by Cleaving Complement Component 4 , 2013, PloS one.

[22]  Y. Kanegae,et al.  Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery , 2013, Scientific Reports.

[23]  Xi Chen,et al.  DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication. , 2013, Virology.

[24]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[25]  P. Schirmacher,et al.  Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. , 2012, Gastroenterology.

[26]  Y. Kanegae,et al.  Copy number of adenoviral vector genome transduced into target cells can be measured using quantitative PCR: application to vector titration. , 2012, Biochemical and biophysical research communications.

[27]  J. Wands,et al.  Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. , 2010, Journal of hepatology.

[28]  E. Tsochatzis,et al.  Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C , 2010, Journal of viral hepatitis.

[29]  K. Ishii,et al.  Production of Infectious Hepatitis C Virus by Using RNA Polymerase I-Mediated Transcription , 2010, Journal of Virology.

[30]  R. Purcell,et al.  Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies , 2010, Journal of Virology.

[31]  D. Girelli,et al.  Reduced serum hepcidin levels in patients with chronic hepatitis C. , 2009, Journal of hepatology.

[32]  R. Kaufman,et al.  ER Stress Controls Iron Metabolism Through Induction of Hepcidin , 2009, Science.

[33]  R. Bartenschlager,et al.  Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor–induced signal transduction by cleavage of the T‐cell protein tyrosine phosphatase , 2009, Hepatology.

[34]  D. Brenner,et al.  Hepatitis C virus–induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity , 2008, Hepatology.

[35]  Jennifer L Luebke-Wheeler,et al.  Hepatocyte nuclear factor 4α is implicated in endoplasmic reticulum stress–induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H , 2008, Hepatology.

[36]  N. Tomosugi,et al.  Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma , 2008, BMC Cancer.

[37]  M. Kanaoka,et al.  Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors. , 2007, Human gene therapy.

[38]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[39]  N. Andrews,et al.  Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.

[40]  F. Chisari,et al.  Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells , 2006, Journal of Virology.

[41]  Randal J. Kaufman,et al.  Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response , 2006, Cell.

[42]  Zhijian J. Chen,et al.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Xiaoling Xu,et al.  A Role of Smad4 in Iron Metabolism through the Positive Regulation of Hepcidin Expression , 2022 .

[44]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[45]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[46]  D. Burton,et al.  Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Ferreon,et al.  Molecular Determinants of TRIF Proteolysis Mediated by the Hepatitis C Virus NS3/4A Protease* , 2005, Journal of Biological Chemistry.

[48]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Hultcrantz,et al.  Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.

[50]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[51]  Stanley M. Lemon,et al.  Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease , 2003, Science.

[52]  Elizabeta Nemeth,et al.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. , 2003, Blood.

[53]  M. Salah,et al.  Methodology , 2003 .

[54]  M. Mattioli,et al.  Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease , 2001, Hepatology.

[55]  R. Kirsch,et al.  Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. , 1996, Journal of hepatology.

[56]  P. Brissot,et al.  Differentiation Between Heterozygotes and Homozygotes in Genetic Hemochromatosis by Means of a Histological Hepatic Iron Index: A Study of 192 Cases , 1993, Hepatology.

[57]  Y. Nan,et al.  A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patients. , 2021, American journal of translational research.

[58]  Xi Chen,et al.  DDB 1 is a cellular substrate of NS 3 / 4 A protease and required for hepatitis C virus replication , 2012 .

[59]  K. Okita,et al.  Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. , 2008, Gastroenterology.

[60]  M. Kaito,et al.  Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C , 2007, Molecular medicine.

[61]  M. Wessling-Resnick,et al.  Iron imports. III. Transfer of iron from the mucosa into circulation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[62]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.